Once a protocol is established, your prescription is filled by a licensed 503A compounding pharmacy and shipped directly to your home anywhere in Utah, Arizona, or Idaho, no pharmacy pickups required
Healthcare providers also see potential cost benefits
The Triple Agonist: Retatrutide Retatrutide is frequently referred to in medical literature as a triple hormone receptor agonist or a triple incretin therapy
Marek focuses on hormone optimization with lab-driven protocols and partner clinicians - Marek is generally more expensive and expects lab testing - Not a direct substitute for a weight-loss-only GLP-1 subscription - See Marek Health reviews Pomegranate Health vs LillyDirect or Novo self-pay: - LillyDirect sells Zepbound to self-pay patients at ~$350-$550/month for FDA-approved product - Novo self-pay options for Wegovy and Ozempic are more limited but expanding - Brand products have published stability, standardized manufacturing, and no compounding regulatory question - Increasingly the default for patients without insurance coverage - See where to buy tirzepatide Pomegranate Health vs a local compounding pharmacy: - Bypasses the telehealth middleman and subscription layer - Requires you to find a PCAB-accredited local compounding pharmacy that can serve you - Usually cheaper per month once the setup is complete, but requires more self-advocacy and often an in-person prescriber - Not practical for patients without a clinician willing to write the prescription The rule of thumb: for most patients, if insurance covers brand GLP-1 use the brand
Therefore, nutritional or pharmaceutical treatments based on amino acids and proteins can be useful in diabetic individuals by improving GLP-1 secretion
"[Foundayo] does allow for scalability, and that will allow us to launch this globally on the first instance," Ricks said
